{"transactions":[{"id":692748,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-08-07T20:22:24.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":20790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") awarded these shares to the Reporting Person in lieu of the cash fees the Reporting Person was entitled to for services rendered as a director of the Company for the first quarter and second quarter of 2026. This grant of shares was approved by the Board on August 5, 2026, subject to the filing by the Company of a Registration Statement on Form S-8 registering the shares, which occurred on August 7, 2026."}],"balance_after":119269,"source":{"system":"sec-edgar","filing":"0001178913-26-003955","document":"zk2635883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891326003955/zk2635883.xml","form_type":"4"}},{"id":909479,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-02-11T13:47:27.000Z","date":"2026-02-10","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":1.48,"value":11100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.4799 inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company (\"Entera Bio\"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"source":{"system":"sec-edgar","filing":"0001178913-26-000414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891326000414/ownership.xml","form_type":"4"}},{"id":954874,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-02T21:17:10.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":33505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2026."}],"balance_after":33505,"derivative":{"exercise_price":1.94,"expiration_date":"2036-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":33505},"source":{"system":"sec-edgar","filing":"0001178913-26-000015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891326000015/ownership.xml","form_type":"4"}},{"id":954873,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-01-02T21:17:10.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":26329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors (\"Board\") of Entera Bio Ltd. (the \"Company\") awarded these shares to the Reporting Persons in lieu of the cash fees the Reported Person was entitled to for services rendered as a director of the Company for the 2025 fiscal year."}],"balance_after":90979,"source":{"system":"sec-edgar","filing":"0001178913-26-000015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891326000015/ownership.xml","form_type":"4"}},{"id":1299660,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-17T21:32:49.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":28509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2025."}],"balance_after":28509,"derivative":{"exercise_price":2.28,"expiration_date":"2035-01-15","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":28509},"source":{"system":"sec-edgar","filing":"0001178913-25-000159","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891325000159/ownership.xml","form_type":"4"}},{"id":1299659,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2025-01-17T21:32:49.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":6922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Board of Directors (\"Board\") of Entera Bio Ltd. (the \"Company\") awarded these shares to the Reporting Persons in lieu of the cash fees the Reported Person was entitled to for services rendered as a director of the Company for the fourth quarter of 2024."}],"balance_after":64650,"source":{"system":"sec-edgar","filing":"0001178913-25-000159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891325000159/ownership.xml","form_type":"4"}},{"id":1390606,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-10-04T20:10:50.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":7278,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57728,"source":{"system":"sec-edgar","filing":"0001178913-24-003222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324003222/ownership.xml","form_type":"4"}},{"id":1419721,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-08-29T20:51:58.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":15335,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50450,"source":{"system":"sec-edgar","filing":"0001178913-24-002895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324002895/ownership.xml","form_type":"4"}},{"id":1678933,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-01-16T13:00:12.000Z","date":"2024-01-12","kind":"purchase","planned":false,"acquired":true,"shares":9500,"price":0.99,"value":9405.0,"ownership":{"direct":true},"balance_after":35115,"source":{"system":"sec-edgar","filing":"0001178913-24-000164","document":"zk2430779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324000164/zk2430779.xml","form_type":"4"}},{"id":1680541,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-01-11T23:14:57.000Z","date":"2024-01-10","kind":"purchase","planned":false,"acquired":true,"shares":7615,"price":0.77,"value":5863.55,"ownership":{"direct":true},"balance_after":25615,"source":{"system":"sec-edgar","filing":"0001178913-24-000135","document":"zk2430773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324000135/zk2430773.xml","form_type":"4"}},{"id":1690782,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T23:59:26.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":108333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2024."}],"balance_after":108333,"derivative":{"exercise_price":0.6,"expiration_date":"2034-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":108333},"source":{"system":"sec-edgar","filing":"0001178913-24-000060","document":"zk2430737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324000060/zk2430737.xml","form_type":"4"}},{"id":1780778,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-09-14T21:03:38.000Z","date":"2023-09-13","kind":"grant","planned":false,"acquired":true,"shares":33368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant of options was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on June 6, 2023, subject to approval by the Company's shareholders, which was obtained on September 13, 2023. The options vest ratably on an annual basis over a three-year period that commenced on June 6, 2023."}],"balance_after":33368,"derivative":{"exercise_price":0.809,"expiration_date":"2033-06-06","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":33368},"source":{"system":"sec-edgar","filing":"0001178913-23-003157","document":"zk2330300.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891323003157/zk2330300.xml","form_type":"4"}},{"id":1797396,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25341,"kind":"person","name":"Taitel Haya","position":1,"cik":"0001979599","reported_name":"Taitel Haya","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2023-08-24T12:12:23.000Z","date":"2023-08-22","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":0.6231,"value":11215.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.619 to $0.626, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company (\"Entera Bio\"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001178913-23-002985","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891323002985/ownership.xml","form_type":"4"}}]}